Underuse of Oral Anticoagulation, High Use of Aspirin and Worse Clinical Outcomes in Patients With Type 2 Diabetes and Atrial Fibrillation: Insights From the TECOS Trial
Publication
, Conference
Guimaraes, P; Lopes, RD; Stevens, SR; Green, JB; McGuire, DK; Holman, RR; Peterson, ED
Published in: CIRCULATION
2017
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
2017
Volume
136
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Guimaraes, P., Lopes, R. D., Stevens, S. R., Green, J. B., McGuire, D. K., Holman, R. R., & Peterson, E. D. (2017). Underuse of Oral Anticoagulation, High Use of Aspirin and Worse Clinical Outcomes in Patients With Type 2 Diabetes and Atrial Fibrillation: Insights From the TECOS Trial. In CIRCULATION (Vol. 136).
Guimaraes, Patricia, Renato D. Lopes, Susanna R. Stevens, Jennifer B. Green, Darren K. McGuire, Rury R. Holman, and Eric D. Peterson. “Underuse of Oral Anticoagulation, High Use of Aspirin and Worse Clinical Outcomes in Patients With Type 2 Diabetes and Atrial Fibrillation: Insights From the TECOS Trial.” In CIRCULATION, Vol. 136, 2017.
Guimaraes P, Lopes RD, Stevens SR, Green JB, McGuire DK, Holman RR, et al. Underuse of Oral Anticoagulation, High Use of Aspirin and Worse Clinical Outcomes in Patients With Type 2 Diabetes and Atrial Fibrillation: Insights From the TECOS Trial. In: CIRCULATION. 2017.
Guimaraes, Patricia, et al. “Underuse of Oral Anticoagulation, High Use of Aspirin and Worse Clinical Outcomes in Patients With Type 2 Diabetes and Atrial Fibrillation: Insights From the TECOS Trial.” CIRCULATION, vol. 136, 2017.
Guimaraes P, Lopes RD, Stevens SR, Green JB, McGuire DK, Holman RR, Peterson ED. Underuse of Oral Anticoagulation, High Use of Aspirin and Worse Clinical Outcomes in Patients With Type 2 Diabetes and Atrial Fibrillation: Insights From the TECOS Trial. CIRCULATION. 2017.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
2017
Volume
136
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology